abstract |
The present invention relates to the use of npolyunsaturated fatty acids and none or more components which have a beneficial effect on total methionine metabolism selected from the group consisting of vitamin B12 and precursors thereof, vitamin B6 and derivatives thereof, folic acid, zinc and magnesium, nand, preferably, nucleotides, nfor reducing the severity of ADHD. |